Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion type Assertion NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_head.
- NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion description "[The N-acetyltransferase (NAT) genes were the most implicated in risk, with the NAT1*10 haplotype showing an inverse association in lung cancer, in both heterozygote carriers [odds ratio (OR), 0.81; 95% confidence interval (95% CI), 0.70-0.93] and homozygote carriers (OR, 0.70; 95% CI, 0.48-1.01), suggesting a genotype dose response (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_provenance.
- NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion evidence source_evidence_literature NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_provenance.
- NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion SIO_000772 18199719 NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_provenance.
- NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion wasDerivedFrom befree-2016 NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_provenance.
- NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_assertion wasGeneratedBy ECO_0000203 NP650299.RAWTieBdP2PMezf7lZs-cBZJoXARCRWrC3E3T14NJVlzQ130_provenance.